# Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare

> **NCT04681482** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 107383 (actual)

## Conditions studied

- Atrial Fibrillation
- Obesity
- Anticoagulants

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04681482
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-02
- **Primary completion:** 2020-11-03
- **Final completion:** 2020-11-03
- **Target enrollment:** 107383 (ACTUAL)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04681482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04681482, "Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04681482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*